Butler S, Ackerman M
Curr Opin Biotechnol. 2024; 90:103216.
PMID: 39437676
PMC: 11627592.
DOI: 10.1016/j.copbio.2024.103216.
Agbakwuru D, Wetzel S
Results Probl Cell Differ. 2024; 73:87-129.
PMID: 39242376
PMC: 11784324.
DOI: 10.1007/978-3-031-62036-2_5.
Sharma P, Sethi R
J Toxicol. 2024; 2024:5261994.
PMID: 39239465
PMC: 11377118.
DOI: 10.1155/2024/5261994.
Kandel A, Li L, Wang Y, Tuo W, Xiao Z
Cells. 2024; 13(9.
PMID: 38727273
PMC: 11083891.
DOI: 10.3390/cells13090738.
Jones M, Castonguay C, Nanaware P, Weaver G, Stadinski B, Kugler-Umana O
J Immunol. 2023; 210(12):1950-1961.
PMID: 37093656
PMC: 10247507.
DOI: 10.4049/jimmunol.2200337.
Toward high-throughput engineering techniques for improving CAR intracellular signaling domains.
Butler S, Hartman C, Huang Y, Ackerman M
Front Bioeng Biotechnol. 2023; 11:1101122.
PMID: 37051270
PMC: 10083361.
DOI: 10.3389/fbioe.2023.1101122.
Activation pathways that drive CD4 T cells to break tolerance in autoimmune diseases.
Krovi S, Kuchroo V
Immunol Rev. 2022; 307(1):161-190.
PMID: 35142369
PMC: 9255211.
DOI: 10.1111/imr.13071.
Lymphocytes and Trogocytosis-Mediated Signaling.
Reed J, Reichelt M, Wetzel S
Cells. 2021; 10(6).
PMID: 34204661
PMC: 8231098.
DOI: 10.3390/cells10061478.
Durable CD4 T-Cell Memory Generation Depends on Persistence of High Levels of Infection at an Effector Checkpoint that Determines Multiple Fates.
Swain S, Jones M, Devarajan P, Xia J, Dutton R, Strutt T
Cold Spring Harb Perspect Biol. 2021; 13(11).
PMID: 33903157
PMC: 8559547.
DOI: 10.1101/cshperspect.a038182.
Recent advances in understanding the Th1/Th2 effector choice.
Butcher M, Zhu J
Fac Rev. 2021; 10:30.
PMID: 33817699
PMC: 8009194.
DOI: 10.12703/r/10-30.
Ceramide Synthase 2 Null Mice Are Protected from Ovalbumin-Induced Asthma with Higher T Cell Receptor Signal Strength in CD4+ T Cells.
Shin S, Cho K, Yoon H, Kim S, Kim H, Pewzner-Jung Y
Int J Mol Sci. 2021; 22(5).
PMID: 33800208
PMC: 7962461.
DOI: 10.3390/ijms22052713.
Discovery of CD80 and CD86 as recent activation markers on regulatory T cells by protein-RNA single-cell analysis.
Trzupek D, Dunstan M, Cutler A, Lee M, Godfrey L, Jarvis L
Genome Med. 2020; 12(1):55.
PMID: 32580776
PMC: 7315544.
DOI: 10.1186/s13073-020-00756-z.
Regulation of T Helper Cell Fate by TCR Signal Strength.
Bhattacharyya N, Feng C
Front Immunol. 2020; 11:624.
PMID: 32508803
PMC: 7248325.
DOI: 10.3389/fimmu.2020.00624.
Recent insights of T cell receptor-mediated signaling pathways for T cell activation and development.
Hwang J, Byeon Y, Kim D, Park S
Exp Mol Med. 2020; 52(5):750-761.
PMID: 32439954
PMC: 7272404.
DOI: 10.1038/s12276-020-0435-8.
Manipulating the TCR signaling network for cellular immunotherapy: Challenges & opportunities.
Matson C, Singh N
Mol Immunol. 2020; 123:64-73.
PMID: 32422416
PMC: 8105766.
DOI: 10.1016/j.molimm.2020.04.007.
Trogocytosis-Mediated Intracellular Signaling in CD4 T Cells Drives T2-Associated Effector Cytokine Production and Differentiation.
Reed J, Wetzel S
J Immunol. 2019; 202(10):2873-2887.
PMID: 30962293
PMC: 6504583.
DOI: 10.4049/jimmunol.1801577.
Chimeric Antigen Receptor Library Screening Using a Novel NF-κB/NFAT Reporter Cell Platform.
Rydzek J, Nerreter T, Peng H, Jutz S, Leitner J, Steinberger P
Mol Ther. 2018; 27(2):287-299.
PMID: 30573301
PMC: 6369451.
DOI: 10.1016/j.ymthe.2018.11.015.
TCR signal strength controls the differentiation of CD4 effector and memory T cells.
Snook J, Kim C, Williams M
Sci Immunol. 2018; 3(25).
PMID: 30030369
PMC: 6126666.
DOI: 10.1126/sciimmunol.aas9103.
PathCORE-T: identifying and visualizing globally co-occurring pathways in large transcriptomic compendia.
Chen K, Tan J, Way G, Doing G, Hogan D, Greene C
BioData Min. 2018; 11:14.
PMID: 29988723
PMC: 6029133.
DOI: 10.1186/s13040-018-0175-7.
TCR Signal Strength Alters T-DC Activation and Interaction Times and Directs the Outcome of Differentiation.
van Panhuys N
Front Immunol. 2016; 7:6.
PMID: 26834747
PMC: 4725058.
DOI: 10.3389/fimmu.2016.00006.